Axiom Space's upcoming Ax-4 mission, launching May 29, 2023, is set to carry a crew of diverse astronauts and conduct nearly 60 scientific investigations with a focus on diabetes management in microgravity. By testing Continuous Glucose Monitors and insulin stability aboard the International Space Station, this mission could shape future diabetes care for astronauts and provide insights that enhance diabetes management in underserved regions on Earth. The findings may change how insulin-dependent individuals approach spaceflight and remote diabetes care, marking a significant advancement in astronaut health.
The Ax-4 mission will test Continuous Glucose Monitors (CGMs) and insulin stability in microgravity, potentially allowing insulin-dependent diabetes patients to participate in spaceflight.
Understanding CGMs and insulin delivery in microgravity can enhance remote diabetes care on Earth, aiding those in isolated environments like oil rigs or rural areas.
Collection
[
|
...
]